![](/img/cover-not-exists.png)
Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group
Ray-Coquard, I, Weber, B, Cretin, J, Haddad-Guichard, Z, Lévy, E, Hardy-Bessard, A C, Gouttebel, M C, Geay, J-F, Aleba, A, Orfeuvre, HVolume:
100
Year:
2009
Language:
english
Pages:
7
DOI:
10.1038/sj.bjc.6604878
File:
PDF, 132 KB
english, 2009